General Information
Revision date
2014-08-30
Product name
CANASA (Mesalamine) SUPPOSITORY
Chemical name
For
CAS No.
89-57-6
1.2.1 Relevant identified uses
of the SUBSTANCE Human Pharmaceutical/Anti-Inflammatory
1.2.2. Uses advised against
Non-Pharmaceutical Use
supplier name
U.S
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Actavis, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@Actavis.com
Section 2
SECTION 2: Hazards identification
Product definition
This product is supplied as bullet shaped, light tan to grey suppositories
Health hazards
Accidental ingestion may be harmful. Inhalation and eye contact may cause irritation. In therapeutic use, the most common adverse reactions reported have included headache, nausea, dizziness, fever, rash, acne, and worsening of ulcerative colitis. Additional symptoms related to rectal administration of the drug are not relevant to workplace exposure. Other adverse effects reported have included renal damage and hypersensitivity reactions, including cardiac hypersensitivity reactions. More information on adverse effects from therapeutic use is described in Section 11 (Toxicological Information). Flammability Hazards: This product is combustible and may ignite if exposed to high temperature for a prolonged period. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon and nitrogen oxides). Reactivity Hazards: This product is not reactive.
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect.
2.3 Other hazards
No other hazard information currently known Emergency Considerations: Emergency responders should wear appropriate protection for situation to which they respond.
